Subscribe to the gold package and get unlimited access to Shamra Academy
Register a new userA flexible Bayesian non-confounding spatial model for analysis of dispersed count data in clinical studies
84
0
0.0
(
0
)
Added by
Mahsa Nadifar
Publication date
2021
fields
Mathematical Statistics
and research's language is
English
Ask ChatGPT about the research
No Arabic abstract
In employing spatial regression models for counts, we usually meet two issues. First, ignoring the inherent collinearity between covariates and the spatial effect would lead to causal inferences. Second, real count data usually reveal over or under-dispersion where the classical Poisson model is not appropriate to use. We propose a flexible Bayesian hierarchical modeling approach by joining non-confounding spatial methodology and a newly reconsidered dispersed count modeling from the renewal theory to control the issues. Specifically, we extend the methodology for analyzing spatial count data based on the gamma distribution assumption for waiting times. The model can be formulated as a latent Gaussian model, and consequently, we can carry out the fast computation using the integrated nested Laplace approximation method. We also examine different popular approaches for handling spatial confounding and compare their performances in the presence of dispersion. We use the proposed methodology to analyze a clinical dataset related to stomach cancer incidence in Slovenia and perform a simulation study to understand the proposed approachs merits better.
rate research
Read More
Bayesian causal inference offers a principled approach to policy evaluation of proposed interventions on mediators or time-varying exposures. We outline a general approach to the estimation of causal quantities for settings with time-varying confounding, such as exposure-induced mediator-outcome confounders. We further extend this approach to propose two Bayesian data fusion (BDF) methods for unmeasured confounding. Using informative priors on quantities relating to the confounding bias parameters, our methods incorporate data from an external source where the confounder is measured in order to make inferences about causal estimands in the main study population. We present results from a simulation study comparing our data fusion methods to two common frequentist correction methods for unmeasured confounding bias in the mediation setting. We also demonstrate our method with an investigation of the role of stage at cancer diagnosis in contributing to Black-White colorectal cancer survival disparities.
Incorporating preclinical animal data, which can be regarded as a special kind of historical data, into phase I clinical trials can improve decision making when very little about human toxicity is known. In this paper, we develop a robust hierarchical modelling approach to leverage animal data into new phase I clinical trials, where we bridge across non-overlapping, potentially heterogeneous patient subgroups. Translation parameters are used to bring both historical and contemporary data onto a common dosing scale. This leads to feasible exchangeability assumptions that the parameter vectors, which underpin the dose-toxicity relationship per study, are assumed to be drawn from a common distribution. Moreover, human dose-toxicity parameter vectors are assumed to be exchangeable either with the standardised, animal study-specific parameter vectors, or between themselves. Possibility of non-exchangeability for each parameter vector is considered to avoid inferences for extreme subgroups being overly influenced by the other. We illustrate the proposed approach with several trial data examples, and evaluate the operating characteristics of our model compared with several alternatives in a simulation study. Numerical results show that our approach yields robust inferences in circumstances, where data from multiple sources are inconsistent and/or the bridging assumptions are incorrect.
Most clinical trials involve the comparison of a new treatment to a control arm (e.g., the standard of care) and the estimation of a treatment effect. External data, including historical clinical trial data and real-world observational data, are commonly available for the control arm. Borrowing information from external data holds the promise of improving the estimation of relevant parameters and increasing the power of detecting a treatment effect if it exists. In this paper, we propose to use Bayesian additive regression trees (BART) for incorporating external data into the analysis of clinical trials, with a specific goal of estimating the conditional or population average treatment effect. BART naturally adjusts for patient-level covariates and captures potentially heterogeneous treatment effects across different data sources, achieving flexible borrowing. Simulation studies demonstrate that BART compares favorably to a hierarchical linear model and a normal-normal hierarchical model. We illustrate the proposed method with an acupuncture trial.
In causal mediation studies that decompose an average treatment effect into a natural indirect effect (NIE) and a natural direct effect (NDE), examples of post-treatment confounding are abundant. Past research has generally considered it infeasible to adjust for a post-treatment confounder of the mediator-outcome relationship due to incomplete information: it is observed under the actual treatment condition while missing under the counterfactual treatment condition. This study proposes a new sensitivity analysis strategy for handling post-treatment confounding and incorporates it into weighting-based causal mediation analysis without making extra identification assumptions. Under the sequential ignorability of the treatment assignment and of the mediator, we obtain the conditional distribution of the post-treatment confounder under the counterfactual treatment as a function of not just pretreatment covariates but also its counterpart under the actual treatment. The sensitivity analysis then generates a bound for the NIE and that for the NDE over a plausible range of the conditional correlation between the post-treatment confounder under the actual and that under the counterfactual conditions. Implemented through either imputation or integration, the strategy is suitable for binary as well as continuous measures of post-treatment confounders. Simulation results demonstrate major strengths and potential limitations of this new solution. A re-analysis of the National Evaluation of Welfare-to-Work Strategies (NEWWS) Riverside data reveals that the initial analytic results are sensitive to omitted post-treatment confounding.
In spatial statistics, it is often assumed that the spatial field of interest is stationary and its covariance has a simple parametric form, but these assumptions are not appropriate in many applications. Given replicate observations of a Gaussian spatial field, we propose nonstationary and nonparametric Bayesian inference on the spatial dependence. Instead of estimating the quadratic (in the number of spatial locations) entries of the covariance matrix, the idea is to infer a near-linear number of nonzero entries in a sparse Cholesky factor of the precision matrix. Our prior assumptions are motivated by recent results on the exponential decay of the entries of this Cholesky factor for Matern-type covariances under a specific ordering scheme. Our methods are highly scalable and parallelizable. We conduct numerical comparisons and apply our methodology to climate-model output, enabling statistical emulation of an expensive physical model.
Log in to be able to interact and post comments
comments
Fetching comments
Sign in to be able to follow your search criteria
